Focusing on cancer treatment, a global
healthcare group led by a UAE-based Indian doctor will set up a new super-specialty
hospital in London, creating about 2,000 new jobs.
The hospital is an effort of the VPS Healthcare group. The new hospital will be
the first private facility in the UK to offer Proton Beam Therapy - a type of
radiotherapy that uses sub-atomic particles to attack cancer cells with less
damage to surrounding tissues than conventional radiotherapy.
Proton beam therapy is currently generally unavailable through the NHS
(National Health Service), though a small number of UK patients are sent abroad
for the treatment if their care team believes they are ideally suited to it.
Dr Shamsheer Vayali, Founder and Managing Director of the VPS Healthcare Group,
said that "the new facility will be created within the historic grade II
listed Royal Masonic Hospital in Hammersmith which closed in 2006."
The facility will open in 2017 with a bed capacity of 150 and will be supported
by around 2,000 staff in jobs ranging from administration, support and service
roles to leading specialist healthcare professionals.
The new 'super-specialty' cancer treatment will be available at the hospital
through the NHS from 2018.
"VPS Healthcare has been encouraged by the UK Government's ongoing policy
to support health and pharmaceutical companies, and we believe that our
investment in this dynamic sector will not only ensure that we play a key role
in supporting this initiative, but will also help to grow and develop the next
generation of medical breakthroughs," said Vayali.
He said that the new London hospital represented a major investment for VPS
Healthcare and is its first entry into the UK market. Welcoming the investment,
the Mayor of London Boris Johnson said: "This is tremendous vote of
confidence in London's thriving life sciences sector as well as the skills and
talent of our amazing healthcare professionals."